Study for Eosinophilic Granulomatosis With Polyangiitis
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Recruiting
Observational Study
Eosinophilic Granulomatosis With Polyangiitis
Churg-Strauss Syndrome
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 700 (estimated)
- Sponsor
- University of Pennsylvania · Other
Who this trial is looking for
This trial is looking for people diagnosed with eosinophilic granulomatosis with polyangiitis. Participants will help researchers discover new ways to measure the severity of this condition over time.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with eosinophilic granulomatosis with polyangiitis.
- A parent or guardian can provide informed consent, if applicable.
You may not be able to join if
- I cannot give informed consent and sign the consent form.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Patients with a diagnosis of eosinophilic granulomatosis with polyangiitis are eligible for the study.
Parent or guardian willing to provide informed consent, if applicable
Exclusion Criteria:
\- Inability to give informed consent and to sign the consent form
Contacts
No contact information available.